DOLLARS AT WORK
Since 2009, The Enbridge Ride to Conquer Cancer presented by Evraz has raised over $60 million for The Alberta Cancer Foundation. The Ride to Conquer Cancer series is Canada’s largest peer-to-peer fundraising event.
Funds raised through Enbridge Ride to Conquer Cancer enable the Alberta Cancer Foundation to support breakthrough cancer research, clinical trials, enhanced care and the discovery of new cancer therapies at the Tom Baker Cancer Centre, Cross Cancer Institute and 15 other centers across Alberta.
As the largest cancer foundation in Alberta, The Alberta Cancer Foundation’s vision is to achieve a cancer-free future, by investing in cancer prevention and screening, enhanced care and research across Alberta.
Funds raised through the Enbridge Ride to Conquer Cancer are powering Research, Clinical Trials and Enhanced Care Programs.
The Alberta Cancer Foundation supports every single clinical trial that takes place in Alberta, and over the past five years the Enbridge Ride to Conquer Cancer has given 6,000 Albertans the opportunity to take part in ground breaking research. Alberta is a national leader in clinical trials and funds raised through The Ride enable patients access to promising new cancer treatments, drugs and therapies. In the last year, 927 people signed up for a clinical trial in Alberta—a six per cent increase from the previous year.
Trials underway examine the efficiency of: hormone therapy, chemotherapy, radiation therapy and immunotherapy, combinations of treatments, and exploring new, less invasive methods of surgery.
No matter where a patient faces a cancer diagnosis in this province, we want to ensure they receive the best possible treatment and care. Alberta Cancer Foundation donors and funds from the Ride enable local support at the Tom Baker Cancer Centre in Calgary, the Cross Cancer Institute in Edmonton and 15 other cancer centres around the province. These investments offer patients and families enhanced care, over and above what is typically provided and may include comfortable reclining chemo chairs, vital sign machines in clinic rooms, patient journals, blanket warmers during radiation treatment or advanced training for staff that helps improve patient care and quality. Programs include:
Net proceeds from The Enbridge® Ride to Conquer Cancer® presented by Evraz will benefit The Alberta Cancer Foundation, the registered charity dedicated to supporting cancer research and programs at the Tom Baker Cancer Centre, the Cross Cancer Institute and 15 other cancer centres across Alberta. We see every day how patients and families benefit from the work that more than 200,000 Alberta Cancer Foundation donors make possible each year. The Foundation provides funding for basic, translational and clinical research, advanced treatment programs, prevention and screening initiatives, equipment and facility enhancements, a patient financial assistance program and psychosocial initiatives at all Alberta cancer centres.
To learn more about the Alberta Cancer Foundation, visit www.albertacancer.ca/
Patients and families across the province count on having access to the most effective programs and best-equipped facilities in Canada, if not the world. Alberta’s team of cancer nurses, radiation therapists, technicians, pharmacists, researchers and doctors are dedicated to giving them the best care available. Research integrated with cancer treatment gives us more information about cancer and provides direct benefits to our patients.
Research also helps us attract and keep the best trained people for cancer care and training of the next generation of specialists. And equipped with cutting-edge technology and state-of-the-art tools, Alberta physicians and researchers are helping to revolutionize the delivery of cancer treatment.
The Tom Baker Cancer Centre in Calgary and the Cross Cancer Institute in Edmonton are leading centres of cancer treatment as well as scientific and clinical research to develop new cancer therapies. Albertans are able to access leading treatments 3-7 years in advance of those treatments becoming available on a large-scale basis.